238 related articles for article (PubMed ID: 34571051)
1. PDLIM2: Signaling pathways and functions in cancer suppression and host immunity.
Guo ZS; Qu Z
Biochim Biophys Acta Rev Cancer; 2021 Dec; 1876(2):188630. PubMed ID: 34571051
[TBL] [Abstract][Full Text] [Related]
2. PDLIM2 repression by ROS in alveolar macrophages promotes lung tumorigenesis.
Li L; Sun F; Han L; Liu X; Xiao Y; Gregory AD; Shapiro SD; Xiao G; Qu Z
JCI Insight; 2021 Mar; 6(5):. PubMed ID: 33539325
[TBL] [Abstract][Full Text] [Related]
3. Causative role of PDLIM2 epigenetic repression in lung cancer and therapeutic resistance.
Sun F; Li L; Yan P; Zhou J; Shapiro SD; Xiao G; Qu Z
Nat Commun; 2019 Nov; 10(1):5324. PubMed ID: 31757943
[TBL] [Abstract][Full Text] [Related]
4. [PDLIM2 and Its Role in Oncogenesis--Tumor Suppressor or Oncoprote?].
Maryáš J; Bouchal P
Klin Onkol; 2015; 28 Suppl 2():2S40-6. PubMed ID: 26374157
[TBL] [Abstract][Full Text] [Related]
5. PDLIM2 acts as a cancer suppressor gene in non-small cell lung cancer via the down regulation of NF-κB signaling.
Shi H; Ji Y; Li W; Zhong Y; Ming Z
Mol Cell Probes; 2020 Oct; 53():101628. PubMed ID: 32621848
[TBL] [Abstract][Full Text] [Related]
6. Oncovirus Kaposi sarcoma herpesvirus (KSHV) represses tumor suppressor PDLIM2 to persistently activate nuclear factor κB (NF-κB) and STAT3 transcription factors for tumorigenesis and tumor maintenance.
Sun F; Xiao Y; Qu Z
J Biol Chem; 2015 Mar; 290(12):7362-8. PubMed ID: 25681443
[TBL] [Abstract][Full Text] [Related]
7. Kruppel like factor 10 up-regulates PDZ and LIM domain containing protein 2 via nuclear factor kappa-B pathway to inhibit proliferation and inflammatory of fibroblastoid synovial cell in rheumatoid arthritis.
Wang S; Zha X; Ruan S; Yao S; Zhang X
Bioengineered; 2022 Jan; 13(1):1779-1790. PubMed ID: 34713769
[TBL] [Abstract][Full Text] [Related]
8. PDLIM2 Is a Marker of Adhesion and β-Catenin Activity in Triple-Negative Breast Cancer.
Cox OT; Edmunds SJ; Simon-Keller K; Li B; Moran B; Buckley NE; Bustamante-Garrido M; Healy N; O'Flanagan CH; Gallagher WM; Kennedy RD; Bernards R; Caldas C; Chin SF; Marx A; O'Connor R
Cancer Res; 2019 May; 79(10):2619-2633. PubMed ID: 30885980
[TBL] [Abstract][Full Text] [Related]
9. A microRNA 221- and 222-mediated feedback loop maintains constitutive activation of NFκB and STAT3 in colorectal cancer cells.
Liu S; Sun X; Wang M; Hou Y; Zhan Y; Jiang Y; Liu Z; Cao X; Chen P; Liu Z; Chen X; Tao Y; Xu C; Mao J; Cheng C; Li C; Hu Y; Wang L; Chin YE; Shi Y; Siebenlist U; Zhang X
Gastroenterology; 2014 Oct; 147(4):847-859.e11. PubMed ID: 24931456
[TBL] [Abstract][Full Text] [Related]
10. PDLIM7 Synergizes With PDLIM2 and p62/Sqstm1 to Inhibit Inflammatory Signaling by Promoting Degradation of the p65 Subunit of NF-κB.
Jodo A; Shibazaki A; Onuma A; Kaisho T; Tanaka T
Front Immunol; 2020; 11():1559. PubMed ID: 32849529
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic repression of PDZ-LIM domain-containing protein 2: implications for the biology and treatment of breast cancer.
Qu Z; Fu J; Yan P; Hu J; Cheng SY; Xiao G
J Biol Chem; 2010 Apr; 285(16):11786-92. PubMed ID: 20185823
[TBL] [Abstract][Full Text] [Related]
12. Essential function for PDLIM2 in cell polarization in three-dimensional cultures by feedback regulation of the β1-integrin-RhoA signaling axis.
Deevi RK; Cox OT; O'Connor R
Neoplasia; 2014 May; 16(5):422-31. PubMed ID: 24863845
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic repression of PDZ-LIM domain-containing protein 2 promotes ovarian cancer via NOS2-derived nitric oxide signaling.
Zhao L; Yu C; Zhou S; Lau WB; Lau B; Luo Z; Lin Q; Yang H; Xuan Y; Yi T; Zhao X; Wei Y
Oncotarget; 2016 Jan; 7(2):1408-20. PubMed ID: 26593252
[TBL] [Abstract][Full Text] [Related]
14. Sequestration of PDLIM2 in the cytoplasm of monocytic/macrophage cells is associated with adhesion and increased nuclear activity of NF-kappaB.
Healy NC; O'Connor R
J Leukoc Biol; 2009 Mar; 85(3):481-90. PubMed ID: 19052146
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of the putative ubiquitin-E3 ligase PDLIM2 in classical Hodgkin and anaplastic large cell lymphoma.
Wurster KD; Hummel F; Richter J; Giefing M; Hartmann S; Hansmann ML; Kreher S; Köchert K; Krappmann D; Klapper W; Hummel M; Wenzel SS; Lenz G; Janz M; Dörken B; Siebert R; Mathas S
Leukemia; 2017 Mar; 31(3):602-613. PubMed ID: 27538486
[TBL] [Abstract][Full Text] [Related]
16. Systematic evaluation of the prognostic and immunological role of PDLIM2 across 33 cancer types.
Zeng Y; Lin D; Gao M; Du G; Cai Y
Sci Rep; 2022 Feb; 12(1):1933. PubMed ID: 35121770
[TBL] [Abstract][Full Text] [Related]
17. Molecular determinants of PDLIM2 in suppressing HTLV-I Tax-mediated tumorigenesis.
Fu J; Yan P; Li S; Qu Z; Xiao G
Oncogene; 2010 Dec; 29(49):6499-507. PubMed ID: 20838382
[TBL] [Abstract][Full Text] [Related]
18. PDLIM2 regulates transcription factor activity in epithelial-to-mesenchymal transition via the COP9 signalosome.
Bowe RA; Cox OT; Ayllón V; Tresse E; Healy NC; Edmunds SJ; Huigsloot M; O'Connor R
Mol Biol Cell; 2014 Jan; 25(1):184-95. PubMed ID: 24196835
[TBL] [Abstract][Full Text] [Related]
19. DNA methylation-dependent repression of PDZ-LIM domain-containing protein 2 in colon cancer and its role as a potential therapeutic target.
Qu Z; Yan P; Fu J; Jiang J; Grusby MJ; Smithgall TE; Xiao G
Cancer Res; 2010 Mar; 70(5):1766-72. PubMed ID: 20145149
[TBL] [Abstract][Full Text] [Related]
20. PDLIM2 suppression efficiently reduces tumor growth and invasiveness of human castration-resistant prostate cancer-like cells.
Kang M; Lee KH; Lee HS; Park YH; Jeong CW; Ku JH; Kim HH; Kwak C
Prostate; 2016 Feb; 76(3):273-85. PubMed ID: 26499308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
